Thank you for your interest in our Accelerating chemical innovation: unveiling Symeres’ Parallel Chemistry whitepaper. We’ve made it available for download below.
What To Do Next
Symeres is a transatlantic partner for small-molecule drug discovery and development, guiding programs from the first spark of discovery through to clinical development and manufacturing.
With eight locations across Europe and North America and more than 30 years of industry experience, we combine deep scientific expertise with an agile, collaborative mindset. Our integrated services span hit identification, medicinal chemistry, ADME-Tox, in vitro biology, and process development through to GMP manufacturing. This breadth enables us to seamlessly connect disciplines, accelerate decision-making, and keep programs moving with clarity and confidence.
